Cite
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer : the Gynecologic Cancer InterGroup-Symptom Benefit Study
MLA
Lee, Yeh Chen, et al. Symptom Burden and Quality of Life with Chemotherapy for Recurrent Ovarian Cancer : The Gynecologic Cancer InterGroup-Symptom Benefit Study. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312835555&authtype=sso&custid=ns315887.
APA
Lee, Y. C., King, M. T., OConnell, R. L., Lanceley, A., Joly, F., Hilpert, F., Davis, A., Roncolato, F. T., Okamoto, A., Bryce, J., Donnellan, P., Oza, A. M., Åvall Lundqvist, E., Berek, J. S., Ledermann, J. A., Berton, D., Sehouli, J., Feeney, A., Kaminsky, M.-C., … Friedlander, M. L. (2022). Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer : the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Chicago
Lee, Yeh Chen, Madeleine T. King, Rachel L. OConnell, Anne Lanceley, Florence Joly, Felix Hilpert, Alison Davis, et al. 2022. “Symptom Burden and Quality of Life with Chemotherapy for Recurrent Ovarian Cancer : The Gynecologic Cancer InterGroup-Symptom Benefit Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312835555&authtype=sso&custid=ns315887.